Cai Lei is determined not to give up. He leads his research team and uses an eye-tracking device to communicate. Even though he knows new drug Rag-17 will not help him because he lacks the targeted genetic mutation, Cai continues to support people with ALS worldwide, funding research and organizing care training for families.